RhumbLine Advisers
CORZ

RhumbLine Advisers’s Core Scientific, Inc. Common Stock CORZ Stock Holding History

RhumbLine Advisers’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-381,739
Closed -$496K – 3055
2022
Q3 		$496K Buy
381,739
+77,561
+25% +$165K ﹤0.01% 2492
2022
Q2 		$453K Buy
+304,178
New +$1.4M ﹤0.01% 2546

Other funds holding CORZ

PFO
Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PWM
Perigon Wealth Management San Francisco, California $5.51B AUM 24.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
STA
Summit Trail Advisors New York $6.98B AUM 19.51% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

RhumbLine Advisers's CORZ Position: Q4 2022 in Review

RhumbLine Advisers sold out of Core Scientific, Inc. Common Stock (CORZ) in Q4 2022, closing a stake of 381,739 shares — an estimated $496K sold.

RhumbLine Advisers first reported a position in CORZ in Q2 2022 and held it in 2 quarters. The position peaked at $496K in Q3 2022. 89 funds tracked by Wall St. Rank hold CORZ as of Q4 2022.

  • RhumbLine Advisers reported no remaining Core Scientific, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • RhumbLine Advisers sold 381,739 Core Scientific, Inc. Common Stock shares in Q4 2022, an estimated $496K.
  • RhumbLine Advisers first reported a position in Core Scientific, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
  • RhumbLine Advisers's Core Scientific, Inc. Common Stock position peaked at $496K in Q3 2022.
  • 89 funds tracked by Wall St. Rank held Core Scientific, Inc. Common Stock as of Q4 2022.

Based on RhumbLine Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.